2 天
The Brighterside of News on MSNNew CAR-T therapy achieved complete remission in 70% of aggressive cancer patientsCAR-T cell therapy has revolutionized the treatment of relapsed and refractory B-acute lymphoblastic leukemia (B-ALL), with ...
Researchers have successfully developed a supercharged iteration of CAR-T cell therapy that can enhance the effectiveness and longevity of the cells, particularly against cancer cells that are harder ...
4 天
Interesting Engineering on MSNUS researchers develop next-gen CAR-T therapy to kill hard-to-treat cancersCART, a next-gen CAR-T therapy for improved targeting and functionality to address this. “ALA-CART improves the ability of ...
Researchers at the University of Colorado Anschutz Medical Campus have successfully developed a supercharged iteration of CAR-T cell therapy that can enhance the effectiveness and longevity of the ...
Researchers at the University of Colorado Anschutz Medical Campus have successfully developed a supercharged iteration of CAR ...
A new study reveals that aspirin can reduce cancer metastasis by stimulating the immune system. Researchers found that ...
Identification of pathway provides mechanistic insights into the anti-metastatic effects of aspirin, as a potential basis for ...
Huntsman Cancer Institute's Discovery Innovations showcase the latest advances in cancer treatment, research, and prevention.
has adopted a positive opinion recommending conditional marketing authorization of linvoseltamab to treat adults with relapsed and refractory (R/R) multiple myeloma (MM). The recommendation is ...
The positive CHMP opinion is supported by data from the pivotal LINKER-MM1 trial, which evaluated linvoseltamab in adults with R/R MM. Earlier this month, the FDA accepted for review the Biologics ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果